Evidence Construction of Chuankezhi Injection Against Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Pharmacology

References

• Gloeckl R, Schneeberger T, Jarosch I, Kenn K. Pulmonary rehabilitation and exercise training in chronic obstructive pulmonary disease. Dtsch Arztebl Int. 2018;115(8):117–123. doi:10.3238/arztebl.2018.0117
   PubMed Web of Science ®Google Scholar
• Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Iyer AS, Sullivan DR, Lindell KO, Reinke LF. The role of palliative care in COPD. Chest. 2022;161(5):1250–1262. doi:10.1016/j.chest.2021.10.032
   PubMed Web of Science ®Google Scholar
• Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2021;203(1):24–36. doi:10.1164/rccm.202009-3533SO
   PubMed Web of Science ®Google Scholar
• MacLeod M, Papi A, Contoli M, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact. Respirology. 2021;26(6):532–551. doi:10.1111/resp.14041
   PubMed Web of Science ®Google Scholar
• Li L, Zhong X, Zheng A, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in Kashi region, northwestern China. Int J Chron Obstruct Pulmon Dis. 2021;16:655–663. doi:10.2147/COPD.S289620
   PubMed Web of Science ®Google Scholar
• Bourbeau J, Bafadhel M, Barnes NC, et al. Benefit/risk profile of single-inhaler triple therapy in COPD. Int J Chron Obstruct Pulmon Dis. 2021;16:499–517. doi:10.2147/COPD.S291967
   PubMed Web of Science ®Google Scholar
• Huang K, Zhang P, Zhang Z, et al. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. doi:10.1016/j.pharmthera.2021.107843
   PubMed Web of Science ®Google Scholar
• Zhang F, Chen X, Wu X, et al. TCM nonpharmacological interventions for chronic obstructive pulmonary disease (COPD): protocol for a systematic review and network meta-analysis. Medicine. 2019;98(23):e15979. doi:10.1097/MD.0000000000015979
   PubMed Web of Science ®Google Scholar
• Xu SJ, Zhu YL, Yu JJ, Sun S, Xu YJ, Yang L. 喘可治注射液中朝藿定A,朝藿定B,朝藿定C和淫羊藿苷在大鼠体内的药物动力学研究 [Pharmacokinetics of epimedin A, B, C and icariin of Chuankezhi injection in rat]. Zhongguo Zhong Yao Za Zhi. 2016;41(1):129–133. Chinese. doi:10.4268/cjcmm20160125
   PubMedGoogle Scholar
• Chen XJ, Tang ZH, Li XW, Xie CX, Lu JJ, Wang YT. Chemical constituents, quality control, and bioactivity of epimedii folium (Yinyanghuo). Am J Chin Med. 2015;43(5):783–834. doi:10.1142/S0192415X15500494
   PubMed Web of Science ®Google Scholar
• Zhao JQ, Shao J, Zhong WW. Clinical study on effect of chuankezhi injection in treating children with bronchial asthma. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004;24(6):511–513.
   PubMedGoogle Scholar
• Yan N, Wen DS, Zhao YR, Xu SJ. Epimedium sagittatum inhibits TLR4/MD-2 mediated NF-kappaB signaling pathway with anti-inflammatory activity. BMC Complement Altern Med. 2018;18(1):303. doi:10.1186/s12906-018-2363-x
   PubMedGoogle Scholar
• Wu J, Xu H, Wong PF, Xia S, Xu J, Dong J. Icaritin attenuates cigarette smoke-mediated oxidative stress in human lung epithelial cells via activation of PI3K-AKT and Nrf2 signaling. Food Chem Toxicol. 2014;64:307–313. doi:10.1016/j.fct.2013.12.006
   PubMed Web of Science ®Google Scholar
• Li M, Zheng W, Zhang C, et al. Chuankezhi injection for asthma: protocol of a systematic review and meta-analysis. Medicine. 2019;98(33):e16630. doi:10.1097/MD.0000000000016630
   PubMed Web of Science ®Google Scholar
• Zhao JJ, Pan K, Wang QJ, et al. Effect of anti-asthma Chinese medicine Chuankezhi on the anti-tumor activity of cytokine-induced killer cells. Chin J Cancer. 2013;32(10):553–560. doi:10.5732/cjc.012.10249
   PubMedGoogle Scholar
• Pan J, Chen Y. Clinical study on Chuankezhi injection in treatment of Chronic Obstructive Pulmonary Diseases of spleen-kidney deficiency syndrome in stable phase. Chinese Archives Traditional Chin Med. 2016;34(01):57–59. doi:10.13193/j.issn.1673-7717.2016.01.015
   Google Scholar
• Shan Y, Guo J, Li G. Clinical effects of Zusanli acupoint injection of Chuankezhi injection combined with routine treatment on chronic obstructive pulmonary disease patients due to lung and Kidney Qi Deficiency. Chinese Traditional Patent Med. 2019;41(04):799–803.
   Google Scholar
• Cohen JF, Deeks JJ, Hooft L, et al. Preferred reporting items for journal and conference abstracts of systematic reviews and meta-analyses of diagnostic test accuracy studies (PRISMA-DTA for Abstracts): checklist, explanation, and elaboration. BMJ. 2021;372:n265. doi:10.1136/bmj.n265
   PubMedGoogle Scholar
• Cumpston M, Li T, Page MJ, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions. Cochrane Database Syst Rev. 2019;10:ED000142. doi:10.1002/14651858.ED000142
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–D612. doi:10.1093/nar/gkaa1074
   PubMed Web of Science ®Google Scholar
• Huang X. The effects of Chuankezhi injection in patients with chronic obstructive pulmonary disease in stable phase. [Master’s Thesis]; 2009.
   Google Scholar
• Jiang J, Zhou X. Curative effect of Chuankezhi injection combined with budesonide and formoterol fumarate powder for inhalation in the treatment of COPD. China Pharm. 2015;18(11):1938–1940.
   Google Scholar
• Li S. Effects of Chuankezhi injection on pulmonary function and PaO2 and PaCO2 levels in COPD patients. Mod Med Health Res Elect J. 2020;4(04):36–38.
   Google Scholar
• Li Z. Clinical value of Chuankezhi injection combined with budesonide in chronic obstructive pulmonary disease. Cont Med Educ. 2022;36(06):129–132.
   Google Scholar
• Xiao Y, Liao W. The efficacy of Chuankezhi combined with Budesonide in the treatment of stable COPD. Mod Diagnos Treat. 2020;31(04):529–530.
   Google Scholar
• Wang K, Dong C. Clinical efficacy of Seretide combined with Chuankezhi injection in the treatment of stabilized stage of COPD. Health Vocat Educ. 2014;32(08):141–143.
   Google Scholar
• Wang X. Analysis on the curative effect of Chuankezhi in the treatment of chronic obstructive pulmonary disease. Chinese Community Doctors. 2017;33:1.
   Google Scholar
• Xu X, Pan J, Chen Y. An investigation on clinical therapeutic effect of acupoint injection combined with health education for treatment of spleen kidney yang deficiency syndrome in patients with chronic obstructive pulmonary disease at stable stage. Chin J Integrat Trad West Med Inten Crit Care. 2015;(6):565–568. doi:10.3969/j.issn.1008-9691.2015.06.002
   Google Scholar
• Yu Z, Li J, Zhu X. The clinical effects of chuankezhi injection on stable-stage patients with chronic obstructive pulmonary disease. J Clin Pulm Med. 2010;15(09):1280–1281.
   Google Scholar
• Yuan H, Wang X. Influence of Chuankezhi injection combined with tiotropium Bromide on lung function and inflammatory factor levels in patients with stable COPD. Clin Med Enginee. 2021;28(03):327–328.
   Google Scholar
• Zhan S, Dong H, Li B. Method of tonifying kidney on the immune function of patients with chronic obstructive pulmonary disease stabilization and the influence of the quality of life. J Liaoning Univ Traditional Chin Med. 2016;18(01):135–138. doi:10.13194/j.issn.1673-842x.2016.01.044
   Google Scholar
• Zhang L. The clinical effects of acupoint injection of Chuankezhi injection on COPD in stable phase based on tonifying kidney. [Master’s Thesis]; 2021.
   Google Scholar
• Zheng L, Zhuo M. Study on the effect of Chuankezhi nebulization on pulmonary function in patients with chronic obstructive pulmonary disease in stable stage. China Health Care & Nutr. 2010;2010:1.
   Google Scholar
• Alcazar-Navarrete B, Jamart L, Sanchez-Covisa J, Juarez M, Graefenhain R, Sicras-Mainar A. Clinical characteristics, treatment persistence, and outcomes among patients with COPD treated with single- or multiple-inhaler triple therapy: a retrospective analysis in Spain. Chest. 2022;162(5):1017–1029. doi:10.1016/j.chest.2022.06.033
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Roman-Rodriguez M, Singh D, Han MK, Rodriguez-Roisin R, Ferguson GT. Goals of COPD treatment: focus on symptoms and exacerbations. Respir Med. 2020;166:105938. doi:10.1016/j.rmed.2020.105938
   PubMed Web of Science ®Google Scholar
• Radicioni G, Ceppe A, Ford AA, et al. Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2021;9(11):1241–1254. doi:10.1016/S2213-2600(21)00079-5
   PubMed Web of Science ®Google Scholar
• Gu XY, Chu X, Zeng XL, Bao HR, Liu XJ. Effects of PM2.5 exposure on the Notch signaling pathway and immune imbalance in chronic obstructive pulmonary disease. Environ Pollut. 2017;226:163–173. doi:10.1016/j.envpol.2017.03.070
   PubMed Web of Science ®Google Scholar
• Wang J, Wu Q, Ding L, et al. Therapeutic effects and molecular mechanisms of bioactive compounds against respiratory diseases: traditional Chinese medicine theory and high-frequency use. Front Pharmacol. 2021;12:734450. doi:10.3389/fphar.2021.734450
   PubMed Web of Science ®Google Scholar
• Li Q, Wang G, Xiong SH, et al. Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-kappaB signalling pathways. J Ethnopharmacol. 2020;261:113095. doi:10.1016/j.jep.2020.113095
   PubMed Web of Science ®Google Scholar
• Rahman MM, Bibi S, Rahaman MS, et al. Natural therapeutics and nutraceuticals for lung diseases: traditional significance, phytochemistry, and pharmacology. Biomed Pharmacother. 2022;150:113041. doi:10.1016/j.biopha.2022.113041
   PubMed Web of Science ®Google Scholar
• Zhang HY, Huang H, Pang LJ, Lv XD, Zheng WD. Effectiveness and safety of acupoint application for chronic obstructive pulmonary disease: a protocol for updated systematic review and meta-analysis. Medicine. 2021;100(18):e25802. doi:10.1097/MD.0000000000025802
   PubMed Web of Science ®Google Scholar
• Choi JY, Yoon HK, Shin KC, et al. CAT Score and SGRQ definitions of chronic bronchitis as an alternative to the classical definition. Int J Chron Obstruct Pulmon Dis. 2019;14:3043–3052. doi:10.2147/COPD.S228307
   PubMed Web of Science ®Google Scholar
• Stamenova V, Liang K, Yang R, et al. Technology-enabled self-management of chronic obstructive pulmonary disease with or without asynchronous remote monitoring: randomized controlled trial. J Med Internet Res. 2020;22(7):e18598. doi:10.2196/18598
   PubMed Web of Science ®Google Scholar
• von Siemens S M, Alter P, Lutter JI, et al. CAT score single item analysis in patients with COPD: results from COSYCONET. Respir Med. 2019;159:105810. doi:10.1016/j.rmed.2019.105810
   PubMed Web of Science ®Google Scholar
• Liu Y, Ruan J, Wan C, Tan J, Wu B, Zhao Z. Canonical correlation analysis of factors that influence quality of life among patients with chronic obstructive pulmonary disease based on QLICD-COPD (V2.0). BMJ Open Respir Res. 2022;9(1):1.
   Web of Science ®Google Scholar
• Diaz AA, Pinto-Plata V, Hernandez C, et al. Emphysema and DLCO predict a clinically important difference for 6MWD decline in COPD. Respir Med. 2015;109(7):882–889. doi:10.1016/j.rmed.2015.04.009
   PubMed Web of Science ®Google Scholar
• Mansour KMK, Goulart CDL, Carvalho-Junior LCS, Trimer R, Borghi-Silva A, Silva A. [Pulmonary function and functional capacity cut-off point to establish sarcopenia and dynapenia in patients with COPD]. Pontos de corte da funcao pulmonar e capacidade funcional determinantes para sarcopenia e dinapenia em pacientes com DPOC. J Bras Pneumol. 2019;45(6):e20180252. Portuguese. doi:10.1590/1806-3713/e20180252
   PubMed Web of Science ®Google Scholar
• Li Y, Yao J, Han C, et al. Quercetin, Inflammation and Immunity. Nutrients. 2016;8(3):167. doi:10.3390/nu8030167
   PubMed Web of Science ®Google Scholar
• Tang J, Diao P, Shu X, Li L, Xiong L. Quercetin and quercitrin attenuates the inflammatory response and oxidative stress in LPS-Induced RAW264.7 cells: in vitro assessment and a theoretical model. Biomed Res Int. 2019;2019:7039802. doi:10.1155/2019/7039802
   PubMed Web of Science ®Google Scholar
• Ganesan S, Faris AN, Comstock AT, et al. Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respir Res. 2010;11:131. doi:10.1186/1465-9921-11-131
   PubMed Web of Science ®Google Scholar
• Aziz N, Kim MY, Cho JY. Anti-inflammatory effects of luteolin: a review of in vitro, in vivo, and in silico studies. J Ethnopharmacol. 2018;225:342–358. doi:10.1016/j.jep.2018.05.019
   PubMed Web of Science ®Google Scholar
• Yang SC, Chen PJ, Chang SH, et al. Luteolin attenuates neutrophilic oxidative stress and inflammatory arthritis by inhibiting Raf1 activity. Biochem Pharmacol. 2018;154:384–396. doi:10.1016/j.bcp.2018.06.003
   PubMed Web of Science ®Google Scholar
• Zhang ZT, Zhang DY, Xie K, Wang CJ, Xu F. Luteolin activates Tregs to promote IL-10 expression and alleviating caspase-11-dependent pyroptosis in sepsis-induced lung injury. Int Immunopharmacol. 2021;99:107914. doi:10.1016/j.intimp.2021.107914
   PubMed Web of Science ®Google Scholar
• Imran M, Salehi B, Sharifi-Rad J, et al. Kaempferol: a key emphasis to its anticancer potential. Molecules. 2019;24(12):1.
   Web of Science ®Google Scholar
• Shi Y, Wu Y, Li F, et al. Identifying the anti-metastasis effect of Anhydroicaritin on breast cancer: coupling network pharmacology with experimental validation. J Ethnopharmacol. 2022;293:115326. doi:10.1016/j.jep.2022.115326
   PubMed Web of Science ®Google Scholar
• Zheng ZG, Zhou YP, Zhang X, et al. Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation. Biochem Pharmacol. 2016;122:42–61. doi:10.1016/j.bcp.2016.10.016
   PubMed Web of Science ®Google Scholar
• Liu R, Hao D, Xu W, et al. beta-Sitosterol modulates macrophage polarization and attenuates rheumatoid inflammation in mice. Pharm Biol. 2019;57(1):161–168. doi:10.1080/13880209.2019.1577461
   PubMed Web of Science ®Google Scholar
• Smolarz B, Szyllo K, Romanowicz H. Endometriosis: epidemiology, Classification, Pathogenesis, Treatment and Genetics (Review of Literature). Int J Mol Sci. 2021;22(19):10554. doi:10.3390/ijms221910554
   PubMed Web of Science ®Google Scholar
• Pan J, Cai X, Zheng X, Zhu X, Feng J, Wang X. Luteolin inhibits viability, migration, angiogenesis and invasion of non-small cell lung cancer vascular endothelial cells via miR-133a-3p/purine rich element binding protein B-mediated MAPK and PI3K/Akt signaling pathways. Tissue Cell. 2022;75:101740. doi:10.1016/j.tice.2022.101740
   PubMed Web of Science ®Google Scholar
• Ji H, Li K, Xu W, Li R, Xie S, Zhu X. Prediction of the mechanisms by which quercetin enhances cisplatin action in cervical cancer: a network pharmacology study and experimental validation. Front Oncol. 2021;11:780387. doi:10.3389/fonc.2021.780387
   PubMed Web of Science ®Google Scholar